Related Experiment Video

Updated: May 6, 2026

Assays for the Degradation of Misfolded Proteins in Cells
10:56

Assays for the Degradation of Misfolded Proteins in Cells

Published on: August 28, 2016

11.7K

A CK2-dependent mechanism for degradation of the PML tumor suppressor

Pier Paolo Scaglioni1, Thomas M Yung, Lu Fan Cai

  • 1Cancer Biology and Genetics Program, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

Cell
|July 29, 2006
PubMed

Insights

Casein kinase 2 (CK2) promotes the degradation of the PML tumor suppressor protein. Inhibiting CK2 restores PML levels and enhances its tumor-suppressive functions, offering a potential therapeutic strategy for cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • The PML tumor suppressor is critical for cell growth suppression, apoptosis, and senescence.
  • Loss of PML is common in human tumors, mediated by poorly understood posttranslational modifications.
  • Casein kinase 2 (CK2) is an oncogenic kinase frequently elevated in human cancers.

Purpose of the Study:

  • To elucidate the posttranslational mechanisms regulating PML protein levels.
  • To investigate the role of CK2 in PML degradation.
  • To evaluate CK2 inhibition as a therapeutic strategy for restoring PML tumor-suppressive functions.

Main Methods:

  • Phosphorylation site mapping of PML by CK2.
  • Ubiquitination assays to assess PML degradation.
  • Generation and testing of CK2-resistant PML mutants.
  • In vivo studies using a mouse model of lung cancer.
  • Pharmacological inhibition of CK2 in cancer cell lines and patient specimens.

Main Results:

  • CK2 directly phosphorylates PML at Ser517, promoting its ubiquitin-mediated degradation.
  • PML mutants resistant to CK2 phosphorylation exhibit enhanced tumor-suppressive activity.
  • Pml inactivation accelerates tumorigenesis in a mouse lung cancer model.
  • CK2 inhibition in vivo boosts PML's tumor-suppressive capacity.
  • An inverse correlation exists between CK2 activity and PML protein levels in human lung cancers.

Conclusions:

  • CK2-mediated phosphorylation at Ser517 is a key mechanism controlling PML protein stability.
  • Targeting CK2 offers a viable therapeutic approach to restore PML function and combat cancer.
  • This study identifies a novel regulatory axis with significant implications for cancer therapy.

More Related Videos

Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis08:55

Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis

Published on: August 7, 2018

10.1K
Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

13.0K

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
32.1K
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
6.6K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
2.5K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.2K